167 related articles for article (PubMed ID: 36032169)
1. Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines.
Cavazzini D; Spagnoli G; Mariz FC; Reggiani F; Maggi S; Franceschi V; Donofrio G; Müller M; Bolchi A; Ottonello S
Front Immunol; 2022; 13():958123. PubMed ID: 36032169
[TBL] [Abstract][Full Text] [Related]
2. Secretory production of designed multipeptides displayed on a thermostable bacterial thioredoxin scaffold in Pichia pastoris.
Spagnoli G; Bolchi A; Cavazzini D; Pouyanfard S; Müller M; Ottonello S
Protein Expr Purif; 2017 Jan; 129():150-157. PubMed ID: 27133916
[TBL] [Abstract][Full Text] [Related]
3. A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.
Canali E; Bolchi A; Spagnoli G; Seitz H; Rubio I; Pertinhez TA; Müller M; Ottonello S
Sci Rep; 2014 Apr; 4():4729. PubMed ID: 24751665
[TBL] [Abstract][Full Text] [Related]
4. Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles.
Spagnoli G; Pouyanfard S; Cavazzini D; Canali E; Maggi S; Tommasino M; Bolchi A; Müller M; Ottonello S
Sci Rep; 2017 Dec; 7(1):18000. PubMed ID: 29269879
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-Displayed Multipeptide Immunogens.
Bolchi A; Canali E; Santoni A; Spagnoli G; Viarisio D; Accardi R; Tommasino M; Müller M; Ottonello S
Methods Mol Biol; 2015; 1348():137-51. PubMed ID: 26424270
[TBL] [Abstract][Full Text] [Related]
6. Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin.
Rubio I; Bolchi A; Moretto N; Canali E; Gissmann L; Tommasino M; Müller M; Ottonello S
Vaccine; 2009 Mar; 27(13):1949-56. PubMed ID: 19368776
[TBL] [Abstract][Full Text] [Related]
7. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932
[TBL] [Abstract][Full Text] [Related]
8. Broad Neutralization Responses Against Oncogenic Human Papillomaviruses Induced by a Minor Capsid L2 Polytope Genetically Incorporated Into Bacterial Ferritin Nanoparticles.
Yang F; Mariz FC; Zhao X; Spagnoli G; Ottonello S; Müller M
Front Immunol; 2020; 11():606569. PubMed ID: 33343580
[TBL] [Abstract][Full Text] [Related]
9. Efficient expression of recombinant human heavy chain ferritin (FTH1) with modified peptides.
Guo J; Xu N; Yao Y; Lin J; Li R; Li JW
Protein Expr Purif; 2017 Mar; 131():101-108. PubMed ID: 28013085
[TBL] [Abstract][Full Text] [Related]
10. Combined prophylactic and therapeutic immune responses against human papillomaviruses induced by a thioredoxin-based L2-E7 nanoparticle vaccine.
Zhao X; Yang F; Mariz F; Osen W; Bolchi A; Ottonello S; Müller M
PLoS Pathog; 2020 Sep; 16(9):e1008827. PubMed ID: 32886721
[TBL] [Abstract][Full Text] [Related]
11. The malaria parasite Plasmodium falciparum possesses a functional thioredoxin system.
Krnajski Z; Gilberger TW; Walter RD; Müller S
Mol Biochem Parasitol; 2001 Feb; 112(2):219-28. PubMed ID: 11223129
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.
Brooks N; Hsu J; Esparon S; Pouniotis D; Pietersz GA
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200528
[TBL] [Abstract][Full Text] [Related]
13. Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination.
Wang K; Yang Y; Xue W; Liu Z
Mol Pharm; 2018 Mar; 15(3):975-984. PubMed ID: 29359945
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine.
Ma J; Xu J; Guan L; Hu T; Liu Q; Xiao J; Zhang Y
Fish Shellfish Immunol; 2014 Jul; 39(1):8-16. PubMed ID: 24746937
[TBL] [Abstract][Full Text] [Related]
15. Efficient cell delivery mediated by lipid-specific endosomal escape of supercharged branched peptides.
Brock DJ; Kustigian L; Jiang M; Graham K; Wang TY; Erazo-Oliveras A; Najjar K; Zhang J; Rye H; Pellois JP
Traffic; 2018 Jun; 19(6):421-435. PubMed ID: 29582528
[TBL] [Abstract][Full Text] [Related]
16. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
Brooks N; Esparon S; Pouniotis D; Pietersz GA
Molecules; 2015 Aug; 20(8):14033-50. PubMed ID: 26247926
[TBL] [Abstract][Full Text] [Related]
17. Bursal peptide BP-IV as a novel immunoadjuvant enhances the protective efficacy of an epitope peptide vaccine containing T and B cell epitopes of the H9N2 avian influenza virus.
Liu Y; Shen T; Zhou J; Chen L; Shi S; Wang X; Zhang M; Wang C; Liao C
Microb Pathog; 2021 Sep; 158():105095. PubMed ID: 34280501
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity and immunogenicity of recombinant proteins comprising African swine fever virus proteins p30 and p54 fused to a cell-penetrating peptide.
Zhang G; Liu W; Gao Z; Yang S; Zhou G; Chang Y; Ma Y; Liang X; Shao J; Chang H
Int Immunopharmacol; 2021 Dec; 101(Pt A):108251. PubMed ID: 34715492
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide.
Gross DA; Leborgne C; Chappert P; Masurier C; Leboeuf M; Monteilhet V; Boutin S; Lemonnier FA; Davoust J; Kichler A
Sci Rep; 2019 Mar; 9(1):3937. PubMed ID: 30850685
[TBL] [Abstract][Full Text] [Related]
20. A Multiple Antigen Peptide Vaccine Containing CD4
Gu Y; Sun X; Huang J; Zhan B; Zhu X
J Immunol Res; 2020; 2020():2074803. PubMed ID: 32377530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
